Low-Dose CT Noninferior for Diagnosing Appendicitis

Share this article:
Low-Dose CT Noninferior for Diagnosing Appendicitis
Low-Dose CT Noninferior for Diagnosing Appendicitis

(HealthDay News) – For young adults with suspected appendicitis, low-dose computed tomography (CT) is noninferior to standard-dose CT with respect to negative appendectomy rates.

Kyuseok Kim, MD, from the Seoul National University College of Medicine in South Korea, and colleagues conducted a single-blind noninferiority trial for 891 patients with suspected appendicitis, aged 15–44 years. Participants were randomly allocated to low-dose CT (444 patients; median radiation dose, 116mGy/cm) or standard-dose CT (447 patients; median radiation dose, 521mGy/cm). The rate of negative appendectomies was measured, with a noninferiority margin of 5.5%.

The researchers found that the negative appendectomy rate was 3.5 and 3.2% in the low-dose and standard-dose CT groups, respectively (difference, 0.3%). There were no significant between-group differences in the appendiceal perforation rate (26.5% for low-dose CT vs. 23.3% for standard-dose CT; P=0.46) or in the proportion of patients who required additional imaging (3.2 and 1.6%, respectively; P=0.09).

"We found that the use of low-dose CT as the first-line imaging test was noninferior to standard-dose CT with respect to the negative appendectomy rate among young adults with suspected appendicitis," the authors write.

The study was supported by a grant from GE Healthcare Medical Diagnostics, Korea.

Full Text (subscription or payment may be required)

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs